Fitness Fanatics: Fast Growth, Weak Cash Conversion

Fitness Fanatics: Fast Growth, Weak Cash Conversion

SERRARI GROUP / ANALYST DESK — US IPO PIPELINE | SPORTS NUTRITION DISTRIBUTION

A proposed $35m share sale would transform a small profitable distributor. Cash conversion, inventory needs and a premium sales multiple are the real IPO tests.

$35m — Illustrative gross IPO at $5 midpoint

+58% — H1 2026 revenue growth year on year

−$0.82m — H1 2026 cash used in operations

SERRARI IPO RESEARCH SERIES | RESEARCH CUT-OFF: 09 NOVEMBER 2026

RESEARCH & MARKET EDUCATION • NOT A SECURITIES OFFER OR PERSONAL ADVICE

Executive take: profitable growth has a funding cost

The issuer is seeking capital mainly to support inventory and expansion, not to repair a disclosed net loss.

What happened

The 3 November amended F-1 proposes 7m ordinary shares at $4–$6 for a prospective Nasdaq Capital Market listing under FIT. The deal has not yet priced.

Why investors care

H1 sales rose 58% to $14.72m and net profit to $0.92m, yet the business used $0.82m of operating cash as receivables and inventory absorbed working capital.

Valuation question

At the $5 midpoint and 22.5m post-issue basic shares, implied equity capitalization is $112.5m, or about 4.20x trailing 12-month sales.

Analyst assessment

This is a distribution and cash-cycle investment case, not a software valuation. The reliability of collections and gross-margin mix must drive scrutiny.

The IPO mechanics: a small company, a large capital raise

Gross proceeds, net proceeds and market capitalization are separate quantities.

Primary offering

Seven million new shares are proposed at $4–$6, yielding $28m–$42m gross; $35m is the midpoint calculation, not completed proceeds.

Post-issue shares

Existing shares total 15.5m, versus 22.5m after the base offer. New shares represent approximately 31.1% of post-offer basic shares.

Net proceeds estimate

The amended filing indicates approximately $30.175m net to the company at the $5 midpoint after commissions and estimated costs.

Not a firm date

Pricing, SEC effectiveness, exchange approval and first trade are pending. The company explicitly says the offering depends on securing a national-exchange listing.

Business model: inventory turns into customer loyalty

FIT distributes sports nutrition products through B2B, B2C and marketing-service channels.

B2B distribution

Supplying retail chains and fitness customers increases volume but at lower unit margins than direct online sales.

B2C sales

Direct channels support higher gross margins; the mix between retail and direct sales materially shapes group profitability.

Marketing services

Supplementary brand services provide earnings but are volatile: the service margin dropped sharply in H1 2026 amid marketing expansion.

Geographical execution

Hong Kong operations lead, alongside China and Malaysia subsidiaries. New product certification, retail relationships and regulatory conditions vary by country.

Revenue growth accelerated, margins did not

USD millions; annual periods and half-years must not be treated as identical windows.

Metric comparison (periods labeled)

FY2024 sales: 19.5m USD · FY2025 sales: 21.4m USD · H1 2025 sales: 9.3m USD · H1 2026 sales: 14.7m USD

Period warning

Full-year figures span 12 months; H1 covers only January–June. Half-year revenue grew ~58% YoY.

Quality signal

H1 gross margin declined by 4.0 percentage points, so sales acceleration did not mean margin expansion.

Profit versus operating cash: the critical divergence

A profitable income statement is not equivalent to strong cash generation.

H1 2026 net income

Net income reached $0.919m from $0.364m a year earlier, consistent with stronger volume and operating profit.

H1 2026 operating cash

Operating activities used $0.822m compared with $0.194m generated in H1 2025. Accounts receivable was a key pressure point.

Financing bridge

H1 net financing cash inflow was $0.975m, chiefly supported by bank borrowing movements; this supported the period-end cash balance.

Working-capital test

Inventory builds and longer customer collection periods can consume IPO proceeds faster than reported profit implies. Focus on receivable ageing and inventory turnover.

Debt, liquidity and proceeds use

The IPO is intended to finance much more than the company’s current annual profits.

Balance-sheet position

At 30 June cash was $1.454m against $10.137m of current bank borrowings. Some loans finance inventories and trade working capital.

Largest earmark

Around 40% of net proceeds is intended for inventory financing and working capital; management specifically references reducing short-term funding reliance.

Other allocations

About 15% product expansion, 7.5% regional staffing and offices, 2.5% CRM, 20% alliances or acquisitions, with the balance for general use.

Disclosure caution

Some prose examples of dollar allocations are rounded differently from exact percentages of estimated net proceeds; the percentages control scenario modelling.

Post-issue valuation and dilution

Ordinary shareholders buy a profitable business plus a large prospective cash infusion.

Midpoint capitalization

22.5m post-issue basic shares x $5 = $112.5m. This is gross equity value, not enterprise value or IPO proceeds.

Trailing revenue basis

FY2025 $21.411m − H1 2025 $9.318m + H1 2026 $14.719m = ~$26.811m trailing revenue, giving ~4.20x P/S.

Investor book-value dilution

Prospectus estimates post-issue net tangible book value at $1.50/share versus $5 issue price: immediate $3.50 or 70% book dilution.

Profit multiple caution

Using FY2025 net income of $1.028m gives a rough 109x earnings multiple at midpoint, but future issued cash and growth can change profits.

IPO price sensitivities: market value is not proceeds

All cases use fixed 22.5m post-offer basic shares and exclude the 15% over-allotment.

Illustrative sensitivity / market values

$4/share: equity value 90.0m USD · $5/share: equity value 112.5m USD · $6/share: equity value 135.0m USD

Simple P/S ratios

Against $26.81m trailing revenue: ~3.36x, 4.20x and 5.04x in the three price scenarios.

Gross offering differs

Gross proceeds at $4/$5/$6 would be $28m/$35m/$42m, before offering expenses.

What higher growth does to gross margins

Mix, procurement and marketing spend can overwhelm the top-line acceleration.

Gross-margin squeeze

H1 consolidated gross margin was 27.8%, down from 31.8% in H1 2025, despite a 37.7% increase in gross profit dollars.

B2B growth channel

Higher-volume B2B sales carry lower gross profit per dollar and demand greater inventory funding.

B2C margin support

Direct-consumer gross margin reached 49.6% in H1 2026, which can protect profitability if customer acquisition costs remain disciplined.

Marketing uncertainty

Marketing-service margin fell to 16% from 70.4%; investors should not apply the previous high-margin segment economics to the expanded strategy.

Risk map: cash-cycle execution is the main vulnerability

Figure: Risk map — cash-cycle execution is the main vulnerability.

Scenario map: four rational interpretations

None of the scenarios is a forecast of stock performance.

Cash-conversion improvement

Net IPO cash lowers short-term borrowing pressure, inventory turns improve and B2C/customer-mix margins stabilize.

Growth without cash

Revenue expands but receivables and stocks rise faster, requiring additional working capital despite accounting profits.

Pricing pressure

B2B share grows, marketing costs increase and group margins compress even while reported sales rise.

Execution failure

Overseas expansion and acquisitions consume funds before delivering acceptable returns; new financing or dilution becomes necessary.

Investor monitoring: what confirms the equity thesis

Focus on objective financial signals after the registration becomes effective.

IPO completion — Actual final offer price, traded shares and cash raised.

Cash conversion — Operating cash flow and receivable days.

Mix — B2B and B2C sales growth with segment margins.

Liquidity — Bank borrowings, covenant headroom and cash.

Inventory — Turns, ageing and potential write-downs.

Governance — Founding shareholder voting power and M&A.

Market assessment: what the evidence supports

Financial and listing facts are separated from analyst scenarios.

Serrari view: growth is credible; valuation needs cash proof

Fitness Fanatics is profitable and growing, but its expanding inventory-driven model has already produced cash outflows despite positive net income. The IPO could materially strengthen its balance sheet; whether it creates lasting shareholder value depends on collection discipline, product mix and capital allocation, not just the first-day trading premium.

$112.5m — Illustrative basic equity capitalization at midpoint

~4.20x — Midpoint price / trailing revenue

−$0.82m — H1 2026 operating cash flow

THE NEXT DECISION POINT

Track actual pricing, receivables and inventory turnover, cash generation, founder ownership and the measurable return on proceeds deployed.

Sources, methodology and limitations

SERRARI GROUP / ANALYST DESK

Use the linked descriptive phrases below to open the supporting filing, announcement or market record.

F1 — 3 November 2026 amended F-1: offer, prospectus, use of proceeds

F2 — 3 November filing index and exhibits

F3 — September amended F-1 for earlier term comparison

F4 — SEC company filing history and current registration status

F5 — Independent IPO filing summary, 3 November 2026

METHODOLOGY & COMPARABILITY

Financial results are drawn from the 3 November 2026 F-1/A (FY2024 and FY2025 audited; six months ended 30 June 2026 unaudited). Capitalization uses 22.5m base post-issue ordinary shares, excluding 15% over-allotment, warrants and later issuances. Trailing sales = FY2025 − H1 2025 + H1 2026. Valuations are arithmetic sensitivity estimates, not forecasts. All amounts USD unless otherwise stated. The issue remains preliminary; pricing and listing date unconfirmed.

ANALYST INTERPRETATION & CAUTIONS

All opinions and risk ranks are qualitative analyst judgments rather than probability estimates or financial advice. Figures are as of the stated source dates, not a real-time quote service. Offering terms can change. No recommendation to buy, sell or subscribe to any security is made.

Prepared 09 November 2026 | Serrari Group | Research and market education